MARKET

ICLR

ICLR

ICON PLC
NASDAQ
218.69
+3.25
+1.51%
After Hours: 218.69 0 0.00% 16:00 12/01 EST
OPEN
215.60
PREV CLOSE
215.44
HIGH
220.92
LOW
212.60
VOLUME
430.99K
TURNOVER
0
52 WEEK HIGH
313.00
52 WEEK LOW
171.43
MARKET CAP
17.86B
P/E (TTM)
38.88
1D
5D
1M
3M
1Y
5Y
Calculating The Intrinsic Value Of ICON Public Limited Company (NASDAQ:ICLR)
How far off is ICON Public Limited Company ( NASDAQ:ICLR ) from its intrinsic value? Using the most recent financial...
Simply Wall St. · 2d ago
ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
DUBLIN, November 23, 2022--ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
Business Wire · 11/23 21:15
Jim Cramer Says This Stock Down 25% This Year Is 'Not To Be Touched, Because They're Doing Very Poorly'
Benzinga · 11/21 13:01
Mizuho Maintains Buy on Icon, Lowers Price Target to $250
Benzinga · 11/10 15:49
--Mizuho Adjusts Price Target on ICON to $250 From $272, Maintains Buy Rating
--Mizuho Adjusts Price Target on ICON to $250 From $272, Maintains Buy Rating
MT Newswires · 11/10 12:00
ICON upgraded to buy at BofA on core growth, deal synergies
Seekingalpha · 11/09 15:36
Where Icon Stands With Analysts
Benzinga · 11/09 14:34
B of A Securities Upgrades Icon to Buy, Lowers Price Target to $260
Benzinga · 11/09 11:30
More
About ICLR
ICON Public Limited Company is a clinical research organisation (CRO). The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. The Company specialises in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.